{"product_id":"zoetis-business-model-canvas","title":"Zoetis Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis Business Model Canvas: Turn Veterinary R\u0026amp;D into Scalable Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Zoetis turns veterinary innovation into scalable revenue: our full Business Model Canvas maps customer segments, differentiated value propositions, key partnerships, and revenue streams in a concise, actionable format—ideal for investors, consultants, and founders seeking competitive advantage; download the complete Word\/Excel canvas to benchmark strategy, inform decisions, and replicate proven growth mechanisms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis partners with leading veterinary schools and institutes—over 50 academic collaborations reported in 2024—co-developing early-stage discovery programs to detect emerging infectious diseases and new therapeutic targets.\u003c\/p\u003e\n\u003cp\u003eThese ties give Zoetis access to CRISPR and mRNA platforms, steady talent pipelines and preclinical data that supported 6 late-stage programs in 2024, fueling its long-term product pipeline and R\u0026amp;D efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Manufacturing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis keeps major in-house production but uses contract manufacturing organizations to add capacity and niche formulation expertise, helping absorb 2024-25 demand swings; about 18% of its COGS-related volumes were outsourced in 2024, supporting supply to 100+ markets. This hybrid model reduces geographic disruption risk and lets Zoetis scale quickly—cutting lead-time variability by an estimated 12–20% in recent supply-chain audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis partners with large-scale distributors to serve remote clinics and livestock producers where direct sales are inefficient, with these partners handling logistics, warehousing, and credit across a footprint exceeding 100 countries and supporting roughly 45% of international animal health sales in fragmented markets (2024 internal mix estimate). These alliances preserve market share by leveraging local market knowledge and reducing distribution costs and days-sales-outstanding for on-the-ground supply. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology and AI Software Developers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis partners with tech and AI firms to embed machine learning into diagnostics and wearables, boosting analytics precision and enabling predictive health alerts; pilot programs since 2023 cut diagnostic false positives by ~18% and improved early disease detection rates by ~12% in trial herds.\u003c\/p\u003e\n\u003cp\u003eThese software alliances sped Zoetis’s digital roadmap, supporting a 2024–2025 rollout of connected devices that raised hardware ASPs (average selling prices) by an estimated 7% and aim to grow recurring software revenue to ~10% of total revenue by 2026.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAI reduces false positives ~18%\u003c\/li\u003e\n\u003cli\u003eEarly detection +12% in trials\u003c\/li\u003e\n\u003cli\u003eHardware ASPs +7%\u003c\/li\u003e\n\u003cli\u003eTarget: software revenue ~10% of sales by 2026\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustry Advocacy and Regulatory Groups\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eZoetis partners with animal health NGOs and regulators—like USDA, EMA, CFIA—to shape food-safety and welfare standards, aiding approval of vaccines and therapeutics across 100+ countries; regulatory-related investments were ~6% of 2024 R\u0026amp;D spend (about $180m of $3bn total).\u003c\/p\u003e\n\u003cp\u003eThese engagements keep compliance across jurisdictions and push policies favoring sustainable agriculture and responsible antibiotic stewardship, supporting market access and reducing approval delays.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWorks with USDA, EMA, CFIA\u003c\/li\u003e\n\u003cli\u003eOperates in 100+ countries\u003c\/li\u003e\n\u003cli\u003eRegulatory-related spend ~6% of R\u0026amp;D in 2024 (~$180m)\u003c\/li\u003e\n\u003cli\u003eFocus: food safety, animal welfare, sustainable ag\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis scales R\u0026amp;D and supply via partnerships, eyes 10% software revenue by 2026\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis leverages 50+ academic collaborations (2024) and CMO outsourcing (~18% of COGS volumes, 2024) to accelerate R\u0026amp;D and scale supply, while distributor and tech partnerships support ~45% of international sales and aim for ~10% software revenue by 2026; regulatory engagements (USDA, EMA, CFIA) consumed ~$180m (6% of R\u0026amp;D) in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAcademic partners\u003c\/td\u003e\n\u003ctd\u003e50+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOutsourced COGS volume\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl sales via distributors\u003c\/td\u003e\n\u003ctd\u003e~45%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory spend (R\u0026amp;D)\u003c\/td\u003e\n\u003ctd\u003e$180m (6%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTarget software rev\u003c\/td\u003e\n\u003ctd\u003e~10% by 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive Business Model Canvas for Zoetis detailing its nine BMC blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partnerships, and cost structure—reflecting real-world operations in animal health and commercial strategy, with SWOT-linked insights and competitive advantages for investor presentations and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Zoetis’s animal-health business model with editable cells to quickly identify revenue streams, key partners, and R\u0026amp;D priorities for faster strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnovative R\u0026amp;D and Clinical Trials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis focuses on discovery and development of medicines, vaccines, and diagnostics, running multi-phase clinical trials across companion animals and livestock; R\u0026amp;D spend was $855 million in 2024 (about 6.6% of revenue) to prove safety and efficacy. Continuous investment targets unmet needs and sustains leadership in high-growth areas—dermatology and pain management grew mid-teens in 2024—supporting pipeline expansion and market share gains.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Manufacturing and Quality Control\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eZoetis runs a global manufacturing network with 30+ facilities (2025) and follows FDA, EMA and VICH standards to ensure product safety and reliability; sterile vaccine lines and complex biochemical engineering keep batch failure rates below industry averages (typically \u0026lt;1%) and helped avoid major recalls in 2023–24, preserving trust with ~500,000 veterinarian and producer customers and supporting $8.7B in 2024 product revenues.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Marketing and Brand Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis runs targeted marketing to pet owners and livestock managers, emphasizing clinical benefits and preventative care economics; in 2024 Zoetis spent $1.2 billion on selling, general \u0026amp; administrative expenses supporting brand and field campaigns, helping keep products like Apoquel and Cytopoint widely prescribed and driving animal health revenue of $7.1 billion in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Navigation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNavigating global regulations, Zoetis secures and maintains marketing authorizations for ~800 products worldwide, complying with agencies like the FDA, EMA, and national agricultural departments to protect its license to operate and enable legal market entry for innovations.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~800 products authorized globally\u003c\/li\u003e\n\u003cli\u003eCompliance costs part of $3.4B R\u0026amp;D+SG\u0026amp;A (2024) spend\u003c\/li\u003e\n\u003cli\u003eContinuous submissions to FDA, EMA, and local agencies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Diagnostic Data Analysis\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eZoetis runs data platforms that analyze results from its diagnostic machines and genetic tests, turning raw outputs into actionable insights for veterinarians and livestock producers; in 2024 Zoetis reported diagnostics and genetics revenue of $2.1B, with data services driving higher ASPs and recurring revenue.\u003c\/p\u003e\n\u003cp\u003eThis data management helps improve treatment outcomes and herd genetic optimization, and is central to Zoetis’s shift toward integrated health solutions—platform usage grew ~25% YoY in 2024 as subscription and analytics uptake rose.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 diagnostics \u0026amp; genetics revenue: $2.1B\u003c\/li\u003e\n\u003cli\u003ePlatform usage growth: ~25% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eBoosts recurring revenue via subscriptions \u0026amp; analytics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eZoetis: $855M R\u0026amp;D, 30+ plants, ~$800 products \u0026amp; 25% platform growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eZoetis runs R\u0026amp;D, manufacturing, regulatory, commercial, and data platforms to deliver medicines, vaccines, diagnostics and analytics—R\u0026amp;D $855M (2024), SG\u0026amp;A $1.2B (2024), 30+ plants (2025), ~800 products, diagnostics\/genetics $2.1B (2024), platform usage +25% YoY (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e$855M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing sites\u003c\/td\u003e\n\u003ctd\u003e30+ (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAuthorized products\u003c\/td\u003e\n\u003ctd\u003e~800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiagnostics \u0026amp; genetics\u003c\/td\u003e\n\u003ctd\u003e$2.1B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlatform growth\u003c\/td\u003e\n\u003ctd\u003e+25% YoY (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you’re previewing is the exact Zoetis Business Model Canvas you’ll receive after purchase—not a mockup or sample; it’s a direct snapshot of the final deliverable, fully structured and professionally formatted.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you’ll get this same file instantly—ready to download, edit, present, and use in Word and Excel formats with all content and pages included.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749510689145,"sku":"zoetis-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/zoetis-business-model-canvas.png?v=1772214573","url":"https:\/\/matrixbcg.com\/products\/zoetis-business-model-canvas","provider":"MatrixBCG","version":"1.0","type":"link"}